BIOLIFE SOLUTIONS INC — Director's Dealing 2020

Nov 17, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-11-12

Reporting Person: DE GREEF RODERICK (CFO & COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-11-12	Common Stock	M	10000	$1.76	Acquired	166293	Direct
2020-11-12	Common Stock	S	10000	$32.10	Disposed	156293	Direct
2020-11-13	Common Stock	M	10000	$1.76	Acquired	166293	Direct
2020-11-13	Common Stock	S	10000	$31.87	Disposed	156293	Direct
2020-11-16	Common Stock	M	10000	$1.76	Acquired	166293	Direct
2020-11-16	Common Stock	S	10000	$31.33	Disposed	156293	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-12	Stock Option (Right to Buy)	$1.76	M	10000	Disposed	2026-03-04	Common Stock (10000)	Direct
2020-11-13	Stock Option (Right to Buy)	$1.76	M	10000	Disposed	2026-03-04	Common Stock (10000)	Direct
2020-11-16	Stock Option (Right to Buy)	$1.76	M	10000	Disposed	2026-03-04	Common Stock (10000)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.76 to $32.45, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.65 to $32.28, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.75 to $31.90, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

F4: The options vested 25% on March 4, 2017 and thereafter, in 36 equal monthly installments.